Devinder Singh Gill

129 papers receiving 9.2k citations

Devinder Singh Gill's Hit Papers

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial 2018 · 469 citations
4690+6+13Years since publication5001k1.5k

Peers

Devinder Singh Gill
Comparison fields: 5 of 97
  • Pathology and Forensic Medicine 4.1k
  • Genetics 2k
  • Hematology 971
  • Oncology 1.4k
  • Immunology 429
Replace Eva K. Kimby with:
Eva K. Kimby Sweden
Michael E. Williams United States
Eric D. Jacobsen United States
Lubomir Sokol United States
Francisco J. Hernandez‐Ilizaliturri United States
Nishitha M Reddy United States
Wojciech J. Jurczak Poland
Francesc Bosch Spain
John William Sweetenham United States
Andrew John Davies United Kingdom
Devinder Singh Gill relative to Eva K. Kimby Sweden Eva K. Kimby's profile →
Citations per field
00.5×1.5×1.9×
Eva K. Kimby · 1×
Citations per year

Countries citing papers authored by Devinder Singh Gill

Since Specialization
Citations

This map shows the geographic impact of Devinder Singh Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devinder Singh Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devinder Singh Gill more than expected).

Fields of papers citing papers by Devinder Singh Gill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devinder Singh Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devinder Singh Gill. The network helps show where Devinder Singh Gill may publish in the future.

Co-authors

The 25 scholars most cited alongside Devinder Singh Gill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Devinder Singh Gill Line = papers co-authored together Devinder Singh Gill links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 134 papers — load more, or switch the sort, to bring in the rest.

#Work
1
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group
Hit paper breakdown →
20061710
2
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
Hit paper breakdown →
20141384
3
Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
Hit paper breakdown →
20101351
4
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
Hit paper breakdown →
2011654
5
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial
Hit paper breakdown →
2018469
6 2009270
7 2015249
8 2012232
9 2006220
10 2010178
11 2019166
12 2007129
13 2016117
14 2002106
15 2006103
16 2022102
17 201295
18 200680
19 201378
20 201576

About Devinder Singh Gill

Devinder Singh Gill is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Oncology and Immunology, having authored 134 papers that have together received 9.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (40 papers), Lymphoma Diagnosis and Treatment (31 papers), Acute Myeloid Leukemia Research (11 papers), Multiple Myeloma Research and Treatments (10 papers), Viral-associated cancers and disorders (10 papers), Hematopoietic Stem Cell Transplantation (5 papers), Clinical Laboratory Practices and Quality Control (3 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (4.1k citations), Genetics (2k citations), Hematology (971 citations), Oncology (1.4k citations) and Immunology (429 citations). Devinder Singh Gill has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Marek Trněný, Norbert Schmitz, Christian Gisselbrecht, Craig H. Moskowitz, David C. Linch, Nicolas Mounier, David D. F. Ma, Bertram Glaß, Jean-baptiste Briere and Nicolas Ketterer. Their work appears in journals such as Blood, British Journal of Haematology, American Journal of Hematology, Haematologica and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact